Healthy Skepticism Library item: 12916

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

de la Fuente Cid R, Varela Román A.
[Wich in the role of the angiotensine II receptor blockers (ARBs) for the treatment of heart failure? Do we work in order to evidence/recomendations or to the pharmaceutical industry pression?].
An Med Interna 2007 Dec; 24:(12):607-9
http://www.ncbi.nlm.nih.gov/pubmed/18279002

Abstract:

Chronic heart failure (CHF) represents the first cause of hospitalitation in persons older than 6o years in our enviroment. Beside its incidence and prevalence is increasing although new therapeutic treatments. We think the recomendations of the guidelines of clinical practise are an important instrument to make decisions, although sometimes it is used a numeric language little clear. We do not have either to forget that sometimes patients selected for the clinical trials aren t really representative. Finally to add that pharmaceutical industry spends a lot of money on investigating active basics, but as company itself is needs to obtain benefits. With all of this, in this article we try to study the role of angiotensin II receptor blockers (ARBs) occuppy in the medic strategy for the planification of a patient s treatment with chronic heart failure.